In cancer, biomarkers undergo significant changes from their normal state. These changes can be due to various factors such as genetic mutations, epigenetic alterations, and changes in protein expression or post-translational modifications. For instance, the overexpression of HER2/neu in breast cancer or mutations in the BRCA1 and BRCA2 genes are well-known examples of biomarker changes.
